HALO Stocks Emerge as Hot Market Theme Investing in What AI Cannot Replace Oil Prices Slide as USIran Talks Show Progress but Key Issues Remain Japans Nikkei 225 Hits Record High as Hong Kong and South Korean Markets Remain Closed for Holidays SEBI Bars Seven Family Members in Social Media PumpandDump Case Alleges 2025 Crore Illegal Gains Micron Technology Could Potentially Reach 1500 Valuation According to Recent Analysis UK Prime Minister Starmer Pledges Social Media Action Following Meeting with Bereaved Parents MSGS Q1 2026 Earnings Heavy EPS Miss Amid Stock Rally Highlights Market Optimism NFLX Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Mixed Results HBANL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment Dawson Geophysical Q2 2019 Earnings EPS Misses Estimates Amid Challenging Environment Valero Energy VLO Q1 2026 Earnings Strong EPS Beat Signals Resilience in Refining Margins PASG Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress PennyMac Mortgage Investment Trust PMT Holds Steady Near Support as Interest Rate Outlook Shifts Power Solutions International PSIX Holds Steady Near Support Amid Low Volatility abrdn Australia Equity Fund IAF Edges Lower Amidst Modest Selling Pressure First Financial Bankshares FFIN Holds at 3224 After Marginal Gain Key Levels in Focus Silvaco Group SVCO Gains 274 as Shares Test Resistance Near 1023 Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Mineral Push Fifth District Bancorp Director Linda Sins Reports Minimal Share Sale Russian Oil Arrivals in Singapore Increase Amid Legal Trade Framework EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns Markets Shift Expectations Fed Rate Hike Scenario Gains Traction After Hot Inflation Data Pokmon Card Market Surges as Nostalgia Speculation and Celebrity Investors Drive MultiMillion Dollar Sales Wall Street Analysts Weigh In on Avery Dennison Prospects and Caution CLDX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline Structure Therapeutics GPCR Shows Modest Gains as Biotech Sentiment Improves